Fannin Innovation Studio


Fannin Innovation Studio is dedicated to developing early-stage pharmaceutical and medical device assets that address vital unmet medical needs. The firm primarily in-licenses promising, early-stage therapeutic and medical device technologies from leading academic investigators, particularly in the Texas Medical Center and on a national stage. Fannin develops and de-risks these technologies through preclinical work and engineering up through early clinical trials, aiming to catalyze the formation of a thriving and sustainable life sciences entrepreneurship ecosystem for local and national markets.

Fannin Innovation Studio

Fannin Innovation Studio


What We Do

Fannin offers hands-on operational experience in early-stage life science development through its internship program, which includes tracks in Therapeutics and Medical Devices. Interns work closely with portfolio companies, learning about biomedical commercialization, due diligence, market analysis, product development, and regulatory requirements.

This program provides real-world experience in life-science product development, focusing on managing research and development activities, intellectual property, business development, regulatory affairs, and financing. Associates build networks in biotechnology and attend industry workshops and conferences.


Investment Range

Investment Stage


Portfolio

Procyrion is currently enrolling in a pivotal trial to evaluate the Aortix device for patients with acute decompensated heart failure who are resistant to diuretic therapy.

#Medical Devices

Pulmotect’s lead product, Pul-042, is a clinical-stage inhaled therapeutic that stimulates the innate immune system to prevent infection.

#Biotechnology

Allterum is developing a monoclonal antibody therapy for the treatment of pediatric T-cell acute lymphoblastic leukemia.

#Biotechnology

Brevitest is a CLIA-certified clinical laboratory that leverages automation and cloud computing to deliver lab-quality results in 15 minutes.

#Clinical Laboratory


Key People

Chairman and Founder

Managing Partner

Chief Financial Officer

Managing Director